SCHEMBL1276336

SCHEMBL1276336

Cc1cccc(-c2cccc(OP(=O)(Oc3cccc(-c4cccc(C)c4C)c3-c3cccc(C)c3C)Oc3cccc(-c4cccc(C)c4C)c3-c3cccc(C)c3C)c2-c2cccc(C)c2C)c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.49
LMNA P02545 3/20 0.38
HTT P42858 2/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.38
CYP3A4 P08684 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
ALDH1A1 P00352 2/20 0.34
APAF1 O14727 1/20 0.34
MITF O75030 1/20 0.34
CYP2C9 P11712 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
POLB P06746 1/20 0.33
HTR1B P28222 1/20 0.33
TSHR P16473 1/20 0.32
ALPL P05186 1/20 0.32
RAB9A P51151 1/20 0.32
GPR84 Q9NQS5 1/20 0.32
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1276339 0.87 INPPL1 (0.47) MAPTLMNAHTTGAAMAPK1
SCHEMBL15811767 0.85 MAPT (0.42) MAPTLMNAHTTGAAMAPK1
SCHEMBL108985 0.80 MAPT (0.71) MAPTLMNAHTTGAAMAPK1
SCHEMBL8153933 0.79 MAPT (0.47) MAPTLMNAHTTGAAMAPK1
SCHEMBL6814025 0.75 MAPT (0.65) MAPTLMNAHTTGAAMAPK1
SCHEMBL3873601 0.73 INPPL1 (0.50) MAPTLMNAHTTGAAMAPK1
SCHEMBL28975675 0.73 MAPT (0.43) MAPTLMNAHTTGAAMAPK1
SCHEMBL15811768 0.72 INPPL1 (0.49) MAPTLMNAHTTGAAMAPK1
SCHEMBL1192357 0.72 L3MBTL1 (0.37) MAPTHTTGAANPSR1GPR84
SCHEMBL29405980 0.72 KDM4E (0.50) MAPTLMNAHTTGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8759411-B2 Derivatives of diphosphines as flame retardants for polyurethanes BASF SE (DE) 2014-06-24 US disclosed
US-8519035-B2 Cyclic phosphines as flame retardants BASF SE (DE) 2013-08-27 US disclosed
US-20120251810-A1 Derivatives of diphosphines as flame retardants in aromatic and/or heteroaromatic epoxy resins BASF SE (DE) 2012-10-04 US disclosed
US-20110263764-A1 CYCLIC PHOSPHINES AS FLAME RETARDANTS BASF SE (DE) 2011-10-27 US disclosed
US-20110190407-A1 DERIVATIVES OF DIPHOSPHINES AS FLAME RETARDANTS FOR POLYURETHANES BASF SE (DE) 2011-08-04 US disclosed
US-20110028603-A1 HYPERBRANCHED POLYMERS AND OLIGOMERS COMPRISING TERMINAL AMINO GROUPS AS CURING AGENTS FOR EPOXY RESINS BASF SE (DE) 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263764-A1 CYCLIC PHOSPHINES AS FLAME RETARDANTS PFAS, PHOSPHO1, PLCG2 MAPT 4119/4885LMNA 3812/4885HTT 3411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.